NCT06702293Recruiting
Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients
Development and Testing of a Digital Psychological Tool to Improve Symptom Burden in Dermatology Patients
Source: ClinicalTrials.gov · Last updated 28 Sept 2026
Brief summary (registry, in English)
Skin diseases, despite low mortality, significantly impair quality of life. This randomised controlled trial evaluates the efficacy of a digital toolkit comprising psychotherapeutic strategies in reducing QoL burden in patients with chronic inflammatory skin conditions. This toolkit is hosted on a mobile application and will be used by study participants randomised to the intervention arm over the 32 week study period.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 690 (estimated)
- First submitted
- 10 Oct 2024
- Start date
- 23 Feb 2026
- Primary completion date
- Dec 2028
- Lead sponsor
- National University Hospital, Singapore
- Diseases
- Atopic dermatitis (eczema), Psoriasis
- NCT number
- NCT06702293
What you commit to
- Study type: Interventional
- Planned participants: 690
- From 23 Feb 2026 to the primary completion date, Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with unstable psychiatric condition, characterized by
- o Hospital inpatient admission for a psychiatric condition or initiation of a psychotropic medication in the prior 3 months
Other illness
- Patients with active psychiatric symptoms (e.g. active suicidal ideation, psychosis, delusions)
- Patients with unstable dermatological condition, characterized by
- Recent flare of the skin condition within the last 2 weeks, including diagnosis of a flare by a doctor, use of systemic steroids, oral antibiotics, wet wrap rescue therapy, oral antivirals, or increase in frequency of phototherapy or dose of systemic medications for the dermatological condition within the last 2 weeks OR
- Any of the following within 3 months
- inpatient admission for a dermatological condition
- Initiation of phototherapy
- Initiation of systemic therapy (conventional immunosuppressive agent, biologics, JAK inhibitors) within the last 3 months.
Who the study is looking for
- Patients with psoriasis, eczema or chronic urticaria diagnosed by a dermatologist
- Aged 16 or older
- Peak pruritus intensity of 4 or more on a 11-point numerical rating scale (0-10, with 10 representing worst itch)
- Able to engage with a mobile application in the English language
Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National University Hospital Coordinator of this site? Confirm its status | Singapore | Singapore | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.